Clinical Scorecard: Investigating Gene Expression Markers Linked to Neutrophil Extracellular Traps for Assessing Mortality Risk in Neonatal Sepsis
At a Glance
Category
Detail
Condition
Neonatal sepsis with associated coagulopathy
Key Mechanisms
Neutrophil extracellular traps (NETs) promote coagulation via platelet activation leading to immunothrombosis and organ failure
Target Population
Neonates (<28 days old) with sepsis
Care Setting
Neonatal intensive care and infectious disease management
Key Highlights
NET gene expression (NET score) strongly predicts mortality risk in neonatal sepsis with AUCs of 88.7% and 85.4% in validation cohorts
NETosis is sequentially linked to coagulation activation and disseminated intravascular coagulation (DIC) in neonates
Age-specific transcriptomic profiling is critical due to unique neonatal immune responses and reliance on innate immunity
Guideline-Based Recommendations
Diagnosis
Use transcriptomic analysis of NET-related gene expression to stratify mortality risk in neonatal sepsis
Incorporate NET score alongside clinical assessment to identify neonates at high risk for sepsis-associated coagulopathy
Management
Consider targeted anticoagulant therapies guided by NET score to address immunothrombosis in neonatal sepsis
Recognize the heterogeneity in neonatal sepsis and tailor interventions based on molecular risk stratification
Monitoring & Follow-up
Monitor NET gene expression dynamics and coagulation parameters to assess progression and response to therapy
Use temporal transcriptomic data to evaluate changes in NETosis and coagulation during septic shock
Risks
Be aware that uncontrolled coagulation activation can lead to microvascular thrombosis and organ failure
Recognize that standard anticoagulant therapies have not uniformly reduced mortality due to patient heterogeneity
Patient & Prescribing Data
Neonates diagnosed with sepsis exhibiting variable risk of coagulopathy and mortality
NET score may identify neonates who could benefit from targeted anticoagulant treatment, improving prognostic accuracy and guiding personalized therapy
Clinical Best Practices
Apply transcriptomic profiling early in neonatal sepsis to detect NETosis-related gene expression changes before protein-level alterations occur
Use batch effect correction and standardized data preprocessing for reliable gene expression analysis
Integrate molecular risk stratification with clinical parameters to optimize management of neonatal sepsis and prevent progression to DIC
